2022
DOI: 10.3390/ijerph19020712
|View full text |Cite
|
Sign up to set email alerts
|

Post-Exposure Prophylaxis and Methamphetamine Use among Young Sexual Minority Men: The P18 Cohort Study

Abstract: Methamphetamine use is associated with increased risk of HIV infection among young sexual minority men (SMM). Post-exposure prophylaxis (PEP) is an effective strategy for individuals who are exposed to HIV, but there is limited research about PEP use among young SMM and its relationship with methamphetamine use. This study analyzes the association between ever PEP use and recent methamphetamine use among young SMM in New York City, using cross-sectional data from the P18 Cohort Study (n = 429). Multivariable l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
1
0
0
Order By: Relevance
“…Further research is needed to explore the PEP-to-PrEP pathway to biomedical HIV prevention, including reasons for uptake of, or declining, PrEP, but our findings illustrate that nearly half (3268/7108, 46%) of the past PEP users are currently taking PrEP. Moreover, our findings about lifetime PEP uptake are higher than prior reports of PEP use more broadly, where a pooled estimate of PEP use was 5.8% in high-income countries in a systematic review [ 33 ]; yet, our nationwide findings find concordance with increasing uptake over time, including similar rates of PEP use reported among young SMM (ie, 11.5% [ 34 ]) and young SMM of color (ie, 15.3% [ 35 ]) in New York City—a high-resource area for HIV prevention.…”
Section: Discussionsupporting
confidence: 54%
“…Further research is needed to explore the PEP-to-PrEP pathway to biomedical HIV prevention, including reasons for uptake of, or declining, PrEP, but our findings illustrate that nearly half (3268/7108, 46%) of the past PEP users are currently taking PrEP. Moreover, our findings about lifetime PEP uptake are higher than prior reports of PEP use more broadly, where a pooled estimate of PEP use was 5.8% in high-income countries in a systematic review [ 33 ]; yet, our nationwide findings find concordance with increasing uptake over time, including similar rates of PEP use reported among young SMM (ie, 11.5% [ 34 ]) and young SMM of color (ie, 15.3% [ 35 ]) in New York City—a high-resource area for HIV prevention.…”
Section: Discussionsupporting
confidence: 54%